AI-generated summary
The authors report a randomized controlled trial of low-level laser therapy in 26 patients with oral squamous cell carcinoma receiving radio-chemotherapy. Laser-treated patients showed less severe mucositis from week 5 than controls, and the authors conclude that the therapy reduced its incidence and severity. The sample was small, and the abstract gives no wavelength or dosing details.
- Participants
- 26
- Who or what was studied
- Patients with oral squamous cell carcinoma undergoing radio-chemotherapy (11 in the laser group, 15 in the control group)
- Limits stated in the abstract
- The abstract reports a small sample of 26 patients and gives no wavelength or dosing details.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Photobiomodulation, Laser, Randomized controlled trial, Oral mucositis, GRADE, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.